Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page, indicating a small metadata update with no substantive changes to the study information.
    Difference
    0.1%
    Check dated 2026-01-14T01:17:53.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added a Locations section with California and updated the revision to v3.3.3; removed California Locations and HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-12-23T09:17:22.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2; no changes to study details, eligibility criteria, or other core content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:06:39.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1 on the page. This appears to be an internal update with no changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:33:36.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The site-wide notice regarding government funding and operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:48:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The screenshots show only minor formatting changes and wording adjustments; there are no changes to core study details such as enrollment, eligibility criteria, primary outcomes, or treatment arms. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:14:23.000Z thumbnail image

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.